Literature DB >> 11479701

Structures of coenzyme F(420) in Mycobacterium species.

T B Bair1, D W Isabelle, L Daniels.   

Abstract

The structure of coenzyme F(420) in Mycobacterium smegmatis was examined using proton NMR, amino acid analysis, and HPLC. The two major F(420) structures were shown to be composed of a chromophore identical to that of F(420) from Methanobacterium thermoautotrophicum, with a side chain of a ribityl residue, a lactyl residue and five or six glutamate groups (F(420)-5 and F(420)-6). Peptidase treatment studies suggested that L-glutamate groups are linked by gamma-glutamyl bonds in the side chain. HPLC analysis indicated that Mycobacterium tuberculosis, Mycobacterium bovis BCG, and Mycobacterium fortuitum have F(420)-5 and F(420)-6 as the predominant structures, whereas Mycobacterium avium contains F(420)-5, F(420)-6 and F(420)-7 in significant amounts. 7,8-Didemethyl 8-hydroxy 5-deazariboflavin (FO), an intermediate in F(420) biosynthesis, accounted for about 1-7% of the total deazaflavin in cells. Peptidase treatment of F(420) created F(420) derivatives that may be useful for the assay of enzymes involved in F(420) biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479701     DOI: 10.1007/s002030100290

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  28 in total

1.  Cloning, expression, purification, crystallization and preliminary X-ray studies of the C-terminal domain of Rv3262 (FbiB) from Mycobacterium tuberculosis.

Authors:  Aisyah M Rehan; Ghader Bashiri; Neil G Paterson; Edward N Baker; Christopher J Squire
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-30

2.  Elongation of the Poly-γ-glutamate Tail of F420 Requires Both Domains of the F420:γ-Glutamyl Ligase (FbiB) of Mycobacterium tuberculosis.

Authors:  Ghader Bashiri; Aisyah M Rehan; Sreevalsan Sreebhavan; Heather M Baker; Edward N Baker; Christopher J Squire
Journal:  J Biol Chem       Date:  2016-02-09       Impact factor: 5.157

3.  Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosis.

Authors:  Ellene H Mashalidis; Apostolos G Gittis; Aurelie Tomczak; Chris Abell; Clifton E Barry; David N Garboczi
Journal:  Protein Sci       Date:  2015-03-10       Impact factor: 6.725

4.  Autofluorescence of mycobacteria as a tool for detection of Mycobacterium tuberculosis.

Authors:  Sol Patiño; Lorenzo Alamo; Mena Cimino; Yveth Casart; Fulvia Bartoli; María J García; Leiria Salazar
Journal:  J Clin Microbiol       Date:  2008-10       Impact factor: 5.948

5.  Unexpected abundance of coenzyme F(420)-dependent enzymes in Mycobacterium tuberculosis and other actinobacteria.

Authors:  Jeremy D Selengut; Daniel H Haft
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

6.  Large-scale production of coenzyme F420-5,6 by using Mycobacterium smegmatis.

Authors:  Dale Isabelle; D Randall Simpson; Lacy Daniels
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 7.  Radical SAM enzymes involved in the biosynthesis of purine-based natural products.

Authors:  Vahe Bandarian
Journal:  Biochim Biophys Acta       Date:  2012-08-03

8.  Use of transposon Tn5367 mutagenesis and a nitroimidazopyran-based selection system to demonstrate a requirement for fbiA and fbiB in coenzyme F(420) biosynthesis by Mycobacterium bovis BCG.

Authors:  K P Choi; T B Bair; Y M Bae; L Daniels
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

9.  Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.

Authors:  Ruben C Hartkoorn; Olga B Ryabova; Laurent R Chiarelli; Giovanna Riccardi; Vadim Makarov; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

10.  Methanococcus jannaschii coenzyme F420 analogs contain a terminal alpha-linked glutamate.

Authors:  Marion Graupner; Robert H White
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.